Company Filing History:
Years Active: 2021
Title: Angelika Freitag: Innovator in Pharmaceutical Composition
Introduction
Angelika Freitag is a notable inventor based in Martinsried, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the formulation of liquid protein compositions. Her innovative work has the potential to enhance the stability and viability of important drug products.
Latest Patents
Angelika Freitag holds a patent for a liquid pharmaceutical composition of etanercept with lysine and proline. This invention relates to novel liquid protein formulations, specifically arginine-free liquid pharmaceutical compositions of etanercept. The formulation employs specific combinations of buffer systems, tonicifiers, and sugar stabilizers, optionally alongside polar ionizable amino acids such as aspartic acid, glutamic acid, histidine, and lysine. This innovative approach aims to provide a viable and storable drug product.
Career Highlights
Freitag is currently associated with Ares Trading S.a., where she continues to develop her expertise in pharmaceutical innovations. Her work has been instrumental in advancing the field of liquid pharmaceutical formulations.
Collaborations
Angelika has collaborated with notable colleagues, including Andrea Hawe and Gianluca Rinaldi, to further her research and development efforts in the pharmaceutical industry.
Conclusion
Angelika Freitag's contributions to the field of pharmaceuticals, particularly through her innovative patent, highlight her role as a leading inventor in the industry. Her work continues to pave the way for advancements in drug formulation and stability.